✦ LIBER ✦

Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial

✍ Scribed by Ludwig Kappos; David Li; Peter A Calabresi; Paul O'Connor; Amit Bar-Or; Frederik Barkhof; Ming Yin; David Leppert; Robert Glanzman; Jeroen Tinbergen; Stephen L Hauser

Book ID: 117309415
Publisher: The Lancet
Year: 2011
Tongue: English
Weight: 337 KB
Volume: 378
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(11)61649-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ocrelizumab in relapsing-remitting multi

Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial

✍ Ludwig Kappos; David Li; Peter A Calabresi; Paul O'Connor; Amit Bar-Or; Frederik 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 337 KB

## Background: B lymphocytes are implicated in the pathogenesis of multiple sclerosis. we aimed to assess efficacy and safety of two dose regimens of the humanised anti-cd20 monoclonal antibody ocrelizumab in patients with relapsing-remitting multiple sclerosis. ## Methods: We did a multicentre,

Firategrast for relapsing remitting mult

Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial

✍ David H Miller; Thomas Weber; Richard Grove; Claire Wardell; Joseph Horrigan; Ol 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 267 KB

Randomised placebo-controlled trial of m

Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis

✍ Franz Fazekas; Florian Deisenhammer; Siegrid Strasser-Fuchs; Gerhard Nahler; Bru 📂 Article 📅 1997 🏛 The Lancet 🌐 English ⚖ 46 KB

Efficacy and safety of oral fumarate in

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

✍ Ludwig Kappos; Ralf Gold; David H Miller; David G MacManus; Eva Havrdova; Volker 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 209 KB

Mitoxantrone in progressive multiple scl

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial

✍ Hans-Peter Hartung; Richard Gonsette; Nikolaus Konig; Hubert Kwiecinski; Andreas 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 115 KB

Randomised double-blind placebo-controll

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

✍ George C Ebers 📂 Article 📅 1998 🏛 The Lancet 🌐 English ⚖ 97 KB